Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

被引：153

作者：

Wang, Li-Tzu ^{[1
,2
]}

Ting, Chiao-Hsuan ^{[1
]}

Yen, Men-Luh ^{[3
,4
]}

Liu, Ko-Jiunn ^{[5
]}

Sytwu, Huey-Kang ^{[2
,6
]}

Wu, Kenneth K. ^{[1
,7
]}

Yen, B. Linju ^{[1
]}

机构：

[1] Natl Hlth Res Inst, Inst Cellular & Syst Med, Regenerat Med Res Grp, 35 Keyan Rd, Zhunan 35053, Taiwan

[2] NDMC, Grad Inst Life Sci, Taipei, Taiwan

[3] Natl Taiwan Univ Hosp, Dept Ob Gyn, Taipei, Taiwan

[4] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[5] NHRI, Natl Inst Canc Res, Tainan, Taiwan

[6] NDMC, Grad Inst Microbiol & Immunol, Taipei, Taiwan

[7] China Med Coll, Grad Inst Basic Med Sci, Taichung, Taiwan

来源：

JOURNAL OF BIOMEDICAL SCIENCE | 2016年 / 23卷

关键词：

Mesenchymal stem cells; Human; Immunomodulation; Inflammation; Clinical trials; Autoimmune disease; Organ transplantation and rejection; Stem cell therapy; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC AIRWAY INFLAMMATION; DSS-INDUCED COLITIS; STROMAL CELLS; MOUSE MODEL; CROHNS-DISEASE; IN-VITRO; LYMPHOCYTE-PROLIFERATION;

D O I：

10.1186/s12929-016-0289-5

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years. Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant. This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune-and inflammation-mediated disease entities. Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary. In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.

引用

页码：1 / 13

页数：13

共 148 条

[1] In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions [J].

Anjos-Afonso, F ;

Siapati, EK ;

Bonnet, D .

JOURNAL OF CELL SCIENCE, 2004, 117 (23) :5655-5664

[2] Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].

Augello, A ;

Tasso, R ;

Negrini, SM ;

Amateis, A ;

Indiveri, F ;

Cancedda, R ;

Pennesi, G .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490

[3] Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation [J].

Auletta, Jeffery J. ;

Eid, Saada K. ;

Wuttisarnwattana, Patiwet ;

Silva, Ines ;

Metheny, Leland ;

Keller, Matthew D. ;

Guardia-Wolff, Rocio ;

Liu, Chen ;

Wang, Fangjing ;

Bowen, Theodore ;

Lee, Zhenghong ;

Solchaga, Luis A. ;

Ganguly, Sudipto ;

Tyler, Megan ;

Wilson, David L. ;

Cooke, Kenneth R. .

STEM CELLS, 2015, 33 (02) :601-614

[4] Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis [J].

Bai, Lianhua ;

Lennon, Donald P. ;

Eaton, Valerie ;

Maier, Kari ;

Caplan, Arnold I. ;

Miller, Stephen D. ;

Miller, Robert H. .

GLIA, 2009, 57 (11) :1192-1203

[5] FAST AND FURIOUS [J].

Baker, Monya .

NATURE, 2009, 458 (7241) :962-965

[6] Mediators of chronic obstructive pulmonary disease [J].

Barnes, PJ .

PHARMACOLOGICAL REVIEWS, 2004, 56 (04) :515-548

[7] Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning [J].

Baron, Frederic ;

Lechanteur, Chantal ;

Willems, Evelyne ;

Bruck, France ;

Baudoux, Etienne ;

Seidel, Laurence ;

Vanbellinghen, Jean-Francois ;

Hafraoui, Kaoutar ;

Lejeune, Marie ;

Gothot, Andre ;

Fillet, Georges ;

Beguin, Yves .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) :838-847

[8] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].

Bartholomew, A ;

Sturgeon, C ;

Siatskas, M ;

Ferrer, K ;

McIntosh, K ;

Patil, S ;

Hardy, W ;

Devine, S ;

Ucker, D ;

Deans, R ;

Moseley, A ;

Hoffman, R .

EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48

[9] T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2 [J].

Ben-Ami, Eyal ;

Miller, Ariel ;

Berrih-Aknin, Sonia .

AUTOIMMUNITY REVIEWS, 2014, 13 (02) :187-196

[10] Synovial tissue inflammation in early and late osteoarthritis [J].

Benito, MJ ;

Veale, DJ ;

Fitzgerald, O ;

van den Berg, WB ;

Bresnihan, B .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) :1263-1267

← 1 2 3 4 5 6 7 8 9 10 →